AKR1C1 expression in the cancer tissue was significantly higher than that in the normal tissue surrounding cancer and was significantly higher in the Ta/T1 bladder cancer tissue than that at the T2/T3 stage. This evidence concerns the gene AKR1C1 and urinary bladder carcinoma.